Search Within

Computational Oncology Service

  1. "Center for Molecular Imaging and Biotechnology"
Formats
  1. Journal Article (186)
  2. Meeting Abstract (147)
  3. Review (8)
  4. Editorial (6)
  5. Conference Paper (3)
  6. Guidelines (2)
  7. Book Section (1)
  8. Research Letter (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (354)
  2. Epidemiology and Biostatistics (354)
  3. GSK Faculty (354)
  4. Human Oncology and Pathogenesis Program (159)
  5. Tow Center for Developmental Oncology (TCDO) (152)
  6. Center for Hematologic Malignancies (148)

More Groups

People
  1. Nikolaus Schultz (135)
  2. Elli Papaemmanuil (128)
  3. Sohrab Shah (42)
  4. Elsa Bernard (30)
  5. Henry Walch (28)
  6. Walid Chatila (27)

More People

Years
  1. 2024 (25)
  2. 2023 (37)
  3. 2022 (67)
  4. 2021 (32)
  5. 2020 (37)
  6. 2019 (41)

More Years

Publications
  1. Blood (59)
  2. Journal of Clinical Oncology (32)
  3. Cancer Research (25)
  4. Nature Communications (9)
  5. Clinical Cancer Research (8)
  6. Neuro-Oncology (8)

More Publications

Publishers
  1. American Society of Hematology (67)
  2. Nature Publishing Group (42)
  3. American Association for Cancer Research (41)
  4. American Society of Clinical Oncology (39)
  5. Cell Press (19)
  6. Oxford University Press (17)

More Publishers

Results (354)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • [The Transcription factor MEF Contributes to stem cell-mediated Genesis of Glioblastoma multiforme]
    Meeting Abstract

    Oberstadt, M.; Bazzoli, E.; Wee, B.; Schultz, N.; Huse, J.; Fomchenko, E.; Voza, F.; Brennan, C.; DeAngelis, L.; Nimer, S.; more...
    Der Internist (2013)

    Fulltext@MSK | Save
  • Cancer cells preferentially lose small chromosomes
    Journal Article

    Duijf, P. H. G.; Schultz, N.; Benezra, R.
    International Journal of Cancer (2013)

    Fulltext@MSK | Save
  • BRCA1 immunohistochemistry in a molecularly characterized cohort of ovarian high-grade serous carcinomas
    Journal Article

    Garg, K.; Levine, D. A.; Olvera, N.; Dao, F.; Bisogna, M.; Secord, A. A.; Berchuck, A.; Cerami, E.; Schultz, N.; Soslow, R. A.
    American Journal of Surgical Pathology (2013)

    Fulltext@MSK | Save
  • The analytic validation of prostate-specific mRNA detection in whole blood by RT-PCR as a prognostic biomarker for patients with castration- resistant prostate cancer (CRPC)
    Meeting Abstract

    Danila, D. C.; Anand, A.; Heller, G.; Wan, M.; Zehnder, M.; Khanin, R.; Schultz, N.; Fleisher, M.; Lilja, H.; Scher, H. I.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Patterns of tumor evolution in high grade serous ovarian carcinoma
    Meeting Abstract

    Verhaak, R. G. W.; Chang, K.; Kim, H.; Carter, S. L.; Schultz, N.; Zhao, F. M.; Shen, H.; Laird, P.; Sinah, R.; Muzny, D.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Identification of the MUC16/CA125 interaction network: Results of a high-throughput yeast two-hybrid screening
    Meeting Abstract

    Polterauer, S.; Thapi, D.; Schultz, N.; Ouerfelli, O.; Chen, N.; Rosales, N.; Yan, X.; Spriggs, D. R.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Will kinase inhibitors make it as glioblastoma drugs?
    Journal Article

    Mellinghoff, I. K.; Schultz, N.; Mischel, P. S.; Cloughesy, T. F.
    Current Topics in Microbiology and Immunology (2012)

    Fulltext@MSK | Save
  • Mef promotes stemness in the pathogenesis of gliomas
    Meeting Abstract

    Bazzoli, E.; Pulvirenti, T.; Oberstadt, M. C.; Perna, F.; Wee, B.; Schultz, N.; Huse, J. T.; Fomchenko, E. I.; Voza, F.; Tabar, V.; more...
    Neuro-Oncology (2012)

    Fulltext@MSK | Save
  • MEF promotes stemness in the pathogenesis of gliomas
    Journal Article

    Bazzoli, E.; Pulvirenti, T.; Oberstadt, M. C.; Perna, F.; Wee, B.; Schultz, N.; Huse, J. T.; Fomchenko, E. I.; Voza, F.; Tabar, V.; more...
    Cell Stem Cell (2012)

    Fulltext@MSK | Save
  • The analytical validation of prostate specific mRNA detection in whole blood by reverse transcription-polymerase chain reaction (RT-PCR) as a prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Danila, D.; Anand, A.; Heller, G.; Wan, M.; Zehnder, M.; Khanin, R.; Schultz, N.; Fleisher, M.; Lilja, H.; Scher, H. I.
    Annals of Oncology (2012)

    Fulltext@MSK | Save